🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Moderna can make 34 custom mRNAs on demand - GMP - IN TWO WEEKS to treat a person with cancer. The same can be true for CRISPR Cures for a devastatingly ill infant who needs a custom gRNA to save their life. Yes it can. Watch this space.

1/3 🧵 Ahead of the UK #GeneralElection2024, we are co-hosting a free science, innovation and technology hustings. Hear directly from political party representatives, & ask them your questions on science policy. Watch live from 6:30pm, Wednesday 19 June youtube.com/live/ok2wzr-ZQ…

This is just so cool. Love it

Big statement alert: This is a LANDMARK in the history of clinical gene editing. This means we can dose to effect. This means we can sequentially edit targets. This means we can reverse certain edits. Cue "A whole new wooorld..."

Our next industrial strategy needs clear choices not jam-spreading, building on what has worked such as catapults ⁦Cell and Gene Therapy Catapult⁩ and industry- driven programmes - sensible advice from Giles Wilkes⁩ instituteforgovernment.org.uk/comment/lesson…

"From today, the policy of this department is that the NHS is broken" - wow. Statement from health secretary Wes Streeting gov.uk/government/spe…

This is correct. Let’s do it!

Investing in health research capacity & skills will be critical for driving future innovations & partnerships, making the most of our health data, assets enabling improvements for patients, thus UK productivity & growth Andrew Morris @emma_k_lowe National Institute for Health and Care Research Office for Life Sciences

CRISPR was just the start

Delighted to be appointed Chair of Warwick Innovation at one of the most exciting times in history for science, technology and innovation. Honoured to build on the huge achievements of Lord Bhattacharyya & colleagues’ work at @wmg, University of Warwick and beyond. #IndustrialStrategy

UK's elite hardware talent is being wasted. ‘Imperial, Oxford, and Cambridge produce world-class engineers. Yet post-graduation, their trajectory is an economic tragedy - and a hidden arbitrage opportunity.’ josef.cn/blog/uk-talent

Interim Innovate UK Executive Chair appointed ukri.org/news/interim-i…

Great #patient #advocacy opportunity here (not that I'm biased)! Please share. Applications open now: see link for further details. #RareDisease #CancerGenomics #GenOMICC #Genomes100k #GenerationStudy Gene People Genetic Alliance UK Cancer52 also on Bluesky @cancer52org.bsky.social Unique

Today, we can announce a new industry-government partnership with up to £400 million of investment to support faster patient access to cutting-edge treatments, strengthen clinical trials, and improve UK medicine manufacturing. Find out more: abpi.org.uk/media/news/202… Department of Health and Social Care

Brilliant! Just brilliant! Congratulations to David, Demis Hassabis and John. So well deserved!

So Jeremy Farrar asked for an "explainer thread" on Noble Prizes in Chemistry around AlphaFold and Protein design, so here goes.

Indeed the opportunity of digital transformation is critical. Co-creating a plan with the NHS workforce, who best know the roadblocks, will be essential. There are plenty of examples of best practice to be rolled out system-wide (PS no Trust is unique!)

Everyone saying “no we can’t let the NHS use a proper joined up digital patient database, it’s all part of a plot to privatise British healthcare and sell your data” should be forced to read the dozens (hundreds?) of case studies like these bbc.co.uk/news/health-67…

We are recruiting up to 5 Pandemic Sciences Research Fellows at University of Oxford. Posts are for recent graduates to carry out independent research on topics in one or more of the following areas: AI & Epi, Genomics, Climate & Infectious diseases, Global health digital data science ↓

#Bluesky nicolemather.bsky.social is moving.. see y’all there